Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Pichler

Showing results (31-40 of 323) with videos related to

Pageof 33
Sort By:
European Urology|November 19, 2021
Targeting c-Met to Improve Immune Checkpoint Inhibition in Metastatic Renal Cell CarcinomaAndrea Katharina Lindner, Martin Pichler, Martin Thurnher, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|September 19, 2018
Early Loss of Forkhead Transcription Factor, O Subgroup, Member 1 Protein in the Development of Pancreatic Ductal AdenocarcinomaWael Al-Zoughbi, Silvia Schauer, Martin Pichler, et al.
Journal of the American College of Cardiology|March 10, 2012
Cardiac fibrosis in human transplanted hearts is mainly driven by cells of intracardiac originMartin Pichler, Peter P Rainer, Silvia Schauer, et al.
Cancer Letters|February 8, 2018
Crosstalk between the Notch signaling pathway and long non-coding RNAsAndreas Reicher, Johannes Foßelteder, Lawrence N Kwong, et al.
Complementary Therapies in Clinical Practice|May 18, 2022
A case report of immediate effects of acupuncture on neuropathic cancer breakthrough painMatthias Huemer, Daniela Jahn-Kuch, Guenter Hofmann, et al.
Expert Opinion on Therapeutic Targets|November 27, 2014
The role of polycomb repressive complexes in biliary tract cancerChristian Mayr, Daniel Neureiter, Andrej Wagner, et al.
Molecular Aspects of Medicine|October 5, 2019
Current concepts of non-coding RNA regulation of immune checkpoints in cancerMaria Anna Smolle, Felix Prinz, George Adrian Calin, et al.
NPJ Precision Oncology|March 15, 2024
ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery frameworkOleg Timofeev, Philippe Giron, Steffen Lawo, et al.
Journal of Clinical Pathology|September 20, 2015
A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment optionsFlorian Eisner, Martin Pichler, Steffen Goletz, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 27, 2015
The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancerOvidiu V Bochis, Alexandru Irimie, Martin Pichler, et al.
Pageof 33

Showing results (31-40 of 323) with videos related to

Sort By:
Pageof 33
European Urology|November 19, 2021
Targeting c-Met to Improve Immune Checkpoint Inhibition in Metastatic Renal Cell CarcinomaAndrea Katharina Lindner, Martin Pichler, Martin Thurnher, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|September 19, 2018
Early Loss of Forkhead Transcription Factor, O Subgroup, Member 1 Protein in the Development of Pancreatic Ductal AdenocarcinomaWael Al-Zoughbi, Silvia Schauer, Martin Pichler, et al.
Journal of the American College of Cardiology|March 10, 2012
Cardiac fibrosis in human transplanted hearts is mainly driven by cells of intracardiac originMartin Pichler, Peter P Rainer, Silvia Schauer, et al.
Cancer Letters|February 8, 2018
Crosstalk between the Notch signaling pathway and long non-coding RNAsAndreas Reicher, Johannes Foßelteder, Lawrence N Kwong, et al.
Complementary Therapies in Clinical Practice|May 18, 2022
A case report of immediate effects of acupuncture on neuropathic cancer breakthrough painMatthias Huemer, Daniela Jahn-Kuch, Guenter Hofmann, et al.
Expert Opinion on Therapeutic Targets|November 27, 2014
The role of polycomb repressive complexes in biliary tract cancerChristian Mayr, Daniel Neureiter, Andrej Wagner, et al.
Molecular Aspects of Medicine|October 5, 2019
Current concepts of non-coding RNA regulation of immune checkpoints in cancerMaria Anna Smolle, Felix Prinz, George Adrian Calin, et al.
NPJ Precision Oncology|March 15, 2024
ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery frameworkOleg Timofeev, Philippe Giron, Steffen Lawo, et al.
Journal of Clinical Pathology|September 20, 2015
A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment optionsFlorian Eisner, Martin Pichler, Steffen Goletz, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 27, 2015
The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancerOvidiu V Bochis, Alexandru Irimie, Martin Pichler, et al.
Pageof 33